Cholera vaccine: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Cholera}} {{CMG}}; '''Associate Editors-In-Chief:''' Priyamvada Singh, MBBS [mailto:psingh@perfuse.org] ==Overview== ==Vaccine== '''Cholera vaccine''' ...")
 
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...)
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Cholera}}
{{Cholera}}
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh@perfuse.org]
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh13579@gmail.com]


==Overview==
==Overview==
==Vaccine==
'''Cholera vaccine''' is a [[vaccine]] used against [[cholera]]<ref>{{MeshName|Cholera+vaccines}}</ref> and [[traveler's diarrhea]].
'''Cholera vaccine''' is a [[vaccine]] used against [[cholera]]<ref>{{MeshName|Cholera+vaccines}}</ref> and [[traveler's diarrhea]].


==Vaccine==
The first vaccines against cholera were developed in the late nineteenth century. These injected whole cell vaccine became increasingly popular until they were replaced by oral vaccines starting in the 1980s. Although no longer in use, the injected cholera vaccines are effective for people living where cholera is endemic. They offer significant degrees of protection for up to two years after a single shot, and for three to four years with annual booster. They reduce the risk of death from cholera by 50% in the first year after vaccination.<ref name="pmid20687062">{{cite journal |author=Graves PM, Deeks JJ, Demicheli V, Jefferson T |title=Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected) |journal=Cochrane Database Syst Rev |issue=8 |pages=CD000974 |year=2010 |doi=10.1002/14651858.CD000974.pub2 |pmid=20687062}}</ref>
The first vaccines against cholera were developed in the late nineteenth century. These injected whole cell vaccine became increasingly popular until they were replaced by oral vaccines starting in the 1980s. Although no longer in use, the injected cholera vaccines are effective for people living where cholera is endemic. They offer significant degrees of protection for up to two years after a single shot, and for three to four years with annual booster. They reduce the risk of death from cholera by 50% in the first year after vaccination.<ref name="pmid20687062">{{cite journal |author=Graves PM, Deeks JJ, Demicheli V, Jefferson T |title=Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected) |journal=Cochrane Database Syst Rev |issue=8 |pages=CD000974 |year=2010 |doi=10.1002/14651858.CD000974.pub2 |pmid=20687062}}</ref>


Line 13: Line 13:


The cholera vaccine is largely used by backpackers and persons visiting locations where there is a high risk of cholera infection. However, since it does not provide 100% immunity from the disease food hygiene precautions should also be taken into consideration when visiting an area where there is a high risk of becoming infected with cholera. Although the protection observed has been described as "moderate", [[herd immunity]] can multiply the effectiveness of vaccination. Although the vaccine can be dangerous for children, administration of the vaccine to adults can confer protection to children indirectly.
The cholera vaccine is largely used by backpackers and persons visiting locations where there is a high risk of cholera infection. However, since it does not provide 100% immunity from the disease food hygiene precautions should also be taken into consideration when visiting an area where there is a high risk of becoming infected with cholera. Although the protection observed has been described as "moderate", [[herd immunity]] can multiply the effectiveness of vaccination. Although the vaccine can be dangerous for children, administration of the vaccine to adults can confer protection to children indirectly.


== References ==
== References ==

Latest revision as of 01:20, 2 November 2012

Cholera Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholera from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Cholera vaccine On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholera vaccine

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholera vaccine

CDC on Cholera vaccine

Cholera vaccine in the news

Blogs on Cholera vaccine

Directions to Hospitals Treating Cholera

Risk calculators and risk factors for Cholera vaccine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Cholera vaccine is a vaccine used against cholera[1] and traveler's diarrhea.

Vaccine

The first vaccines against cholera were developed in the late nineteenth century. These injected whole cell vaccine became increasingly popular until they were replaced by oral vaccines starting in the 1980s. Although no longer in use, the injected cholera vaccines are effective for people living where cholera is endemic. They offer significant degrees of protection for up to two years after a single shot, and for three to four years with annual booster. They reduce the risk of death from cholera by 50% in the first year after vaccination.[2]

There are two variants of the oral vaccine currently in use: WC-rBS and BivWC. WC-rBS (marketed as "Dukoral") is a monovalent inactivated vaccine containing killed whole cells of V. cholerae O1 plus additional recombinant cholera toxin B subunit. BivWC (marketed as "Shanchol" and "mORCVAX") is a bivalent inactivated vaccine containing killed whole cells of V. cholerae O1 and V. cholerae O139. mORCVAX is only available in Vietnam. These oral vaccines provide protection in 52% of cases the first year following vaccination and in 62% of cases the second year.[3]

Bacterial strains of both Inaba and Ogawa serotypes and of El Tor and Classical biotypes are included in the vaccine. Dukoral is taken orally with bicarbonate buffer, which protects the antigens from the gastric acid. The vaccine acts by inducing antibodies against both the bacterial components and CTB. The antibacterial intestinal antibodies prevent the bacteria from attaching to the intestinal wall thereby impeding colonisation of V. cholerae O1. The anti-toxin intestinal antibodies prevent the cholera toxin from binding to the intestinal mucosal surface thereby preventing the toxin-mediated diarrhoeal symptoms. Dukoral also protects against traveler's diarrhea.

The cholera vaccine is largely used by backpackers and persons visiting locations where there is a high risk of cholera infection. However, since it does not provide 100% immunity from the disease food hygiene precautions should also be taken into consideration when visiting an area where there is a high risk of becoming infected with cholera. Although the protection observed has been described as "moderate", herd immunity can multiply the effectiveness of vaccination. Although the vaccine can be dangerous for children, administration of the vaccine to adults can confer protection to children indirectly.

References

  1. Cholera+vaccines at the US National Library of Medicine Medical Subject Headings (MeSH)
  2. Graves PM, Deeks JJ, Demicheli V, Jefferson T (2010). "Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)". Cochrane Database Syst Rev (8): CD000974. doi:10.1002/14651858.CD000974.pub2. PMID 20687062.
  3. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM (2011). "Oral vaccines for preventing cholera". Cochrane Database Syst Rev (3): CD008603. doi:10.1002/14651858.CD008603.pub2. PMID 21412922.

External links


Template:WikiDoc Sources